Drug Approval | May 07, 2026
Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Approval strengthens the company’s growing international anti-infective portfolio
Approval strengthens the company’s growing international anti-infective portfolio
The NIRSE-GAL study, conducted in Galicia, Spain, is the first real-world, population-based investigation of a universal RSV immunization program spanning two consecutive seasons
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
Wockhardt's yet another novel antibiotic Miqnaf receives favourable recommendation from Subject Expert Committee of CDSCO
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
The product is being launched in August 2023
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Pfizer is likely to show GSK significant competition
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Subscribe To Our Newsletter & Stay Updated
